Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (111-120 of 853) with videos related to

Pageof 86
Sort By:
BMJ Open Ophthalmology|January 23, 2018
Facilitating a close interaction between basic, translational and clinical science: <i>BMJ Open Ophthalmology</i>Colin E Willoughby, Stephen B Kaye
Biochemical Society Transactions|February 1, 1980
The fate of liposome-entrapped actinomycin D in vivo and its therapeutic effect in a solid murine tumour [proceedings]S B Kaye, B E Ryman
Investigative Ophthalmology & Visual Science|May 27, 2004
Binocular visual field changes after surgery in esotropic amblyopiaSay Aun Quah, Stephen B Kaye
European Journal of Cancer & Clinical Oncology|September 1, 1989
Flavone acetic acid--preclinical and clinical activityD J Kerr, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Treatment for poor prognosis metastatic germ-cell tumours: much heat but, as yet, little lightD A Anthoney, S B Kaye
Postgraduate Medical Journal|May 1, 1977
Inappropriate anti-diuretic hormone (ADH) secretion in association with carcinoma of the bladderS B Kaye, E J Ross
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1991
Chemoembolism in cancer chemotherapyD J Kerr, S B Kaye
Seminars in Oncology|August 10, 2002
Docetaxel in ovarian cancer: phase III perspectives and future developmentStanley B Kaye, Paul A Vasey
Expert Review of Anticancer Therapy|May 10, 2005
Docetaxel in the management of ovarian cancerSarah P Blagden, Stan B Kaye
Eye (London, England)|April 8, 2026
Comment on: 'Metagenomic next-generation sequencing: a game changer in the diagnosis of unique intraocular infections'T F Somerville, S B Kaye
Pageof 86

Showing results (111-120 of 853) with videos related to

Sort By:
Pageof 86
BMJ Open Ophthalmology|January 23, 2018
Facilitating a close interaction between basic, translational and clinical science: <i>BMJ Open Ophthalmology</i>Colin E Willoughby, Stephen B Kaye
Biochemical Society Transactions|February 1, 1980
The fate of liposome-entrapped actinomycin D in vivo and its therapeutic effect in a solid murine tumour [proceedings]S B Kaye, B E Ryman
Investigative Ophthalmology & Visual Science|May 27, 2004
Binocular visual field changes after surgery in esotropic amblyopiaSay Aun Quah, Stephen B Kaye
European Journal of Cancer & Clinical Oncology|September 1, 1989
Flavone acetic acid--preclinical and clinical activityD J Kerr, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Treatment for poor prognosis metastatic germ-cell tumours: much heat but, as yet, little lightD A Anthoney, S B Kaye
Postgraduate Medical Journal|May 1, 1977
Inappropriate anti-diuretic hormone (ADH) secretion in association with carcinoma of the bladderS B Kaye, E J Ross
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1991
Chemoembolism in cancer chemotherapyD J Kerr, S B Kaye
Seminars in Oncology|August 10, 2002
Docetaxel in ovarian cancer: phase III perspectives and future developmentStanley B Kaye, Paul A Vasey
Expert Review of Anticancer Therapy|May 10, 2005
Docetaxel in the management of ovarian cancerSarah P Blagden, Stan B Kaye
Eye (London, England)|April 8, 2026
Comment on: 'Metagenomic next-generation sequencing: a game changer in the diagnosis of unique intraocular infections'T F Somerville, S B Kaye
Pageof 86